Beginning the Journey - diagnosed 0-3 years

Edgewise CureDuchenne Workshop Presentation

Edgewise Therapeutics: Focused on Muscle Disease

Developing a novel therapeutic designed to protect muscle in Becker and Duchenne muscular dystrophy

Joanne Donovan, MD, PhD
Chief Medical Officer

Joanne Donovan, MD, PhD

Chief Medical Officer

Edgewise Therapeutics

Edgewise Therapeutics

Edgewise Therapeutics Industry Presentation

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on creating novel precision medicines for the treatment of rare muscle disorders. Our intimate knowledge of integrated muscle physiology at a whole-body level allows us to develop innovative solutions for patients with muscle disease where significant unmet medical need exists. By protecting and improving muscle health, our goal is to dramatically enhance the lives of people living with progressive muscle disorders.

Joanne Donovan, MD, PhD

Chief Medical Officer

Edgewise Therapeutics